SAN FRANCISCO , Nov. 20, 2024 /PRNewswire/ -- Astellas Pharma U.S.
, Inc. (President: Mike Petroutsas , "Astellas") today announced that it has entered into an agreement with Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, to pilot DIGITIVATM, a non-invasive digital health solution for the management of heart failure patients. In the next few weeks, eligible patients receiving care with DOHC will begin using DIGITIVA as a new method for managing their heart health while working in partnership with their healthcare team.
DIGITIVA was designed with the goal of improving heart failure management by providing patients with the CORE 500TM Digital Stethoscope developed by Eko Health Inc. and an easy-to-use smartphone app built on the Welldoc, Inc. platform, with AI-driven personalized digital coaching, as well as educational resources from the American Heart Association.
Clinicians also receive tailored patient reports assessed by a clinical review team, highlighting relevant cardioacoustic biomarkers, such as S3 sounds and EMAT (electromechanical activation time), as well as physiological parameters with the goal of enabling earlier intervention when needed. The partnership will also gather data to evaluate the effectiveness of DIGITIVA based on key clinical measures and cost of care metrics relevant to patients, healthcare providers and the overall health care system. In addition, patients will complete the Kansas City Cardiomyopathy Questionnaire (KCCQ), wh.